Pseudoprogression presenting as intestinal perforation in non-small cell lung cancer treated with anti-PD-1: A case report

Pseudoprogression is not frequently observed in patients with non-small cell lung cancer (NSCLC) who are treated with immune checkpoint inhibitors. We report on a case of pseudoprogression, which was presented as intestinal perforation after pembrolizumab immunotherapy for NSCLC. A-54-year-old man w...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Mol Clin Oncol
Huvudupphovsmän: Kim, Hee Kyung, Baek, Seung-Woo, Jeong, Yusook, Yang, Yaewon, Kwon, Jihyun, Han, Hye Sook, An, Jin-Young, Woo, Chang Gok, Lee, Ok-Jun, Lee, Taek Gu, Lee, Ki Hyeong
Materialtyp: Artigo
Språk:Inglês
Publicerad: D.A. Spandidos 2019
Ämnen:
Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6589934/
https://ncbi.nlm.nih.gov/pubmed/31281646
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2019.1871
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk